KR880012579A - 니트로 에텐 유도체의 제조방법 - Google Patents

니트로 에텐 유도체의 제조방법 Download PDF

Info

Publication number
KR880012579A
KR880012579A KR1019880003645A KR880003645A KR880012579A KR 880012579 A KR880012579 A KR 880012579A KR 1019880003645 A KR1019880003645 A KR 1019880003645A KR 880003645 A KR880003645 A KR 880003645A KR 880012579 A KR880012579 A KR 880012579A
Authority
KR
South Korea
Prior art keywords
formula
compound
nitroethane
methyl
iii
Prior art date
Application number
KR1019880003645A
Other languages
English (en)
Other versions
KR940010179B1 (ko
Inventor
묄스도르프 페테르
쉬카네더 헬무트
아렌스 쿠르트헤닝
Original Assignee
카.하.아렌스
호이만 파마 게엠베하 운트 콤파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카.하.아렌스, 호이만 파마 게엠베하 운트 콤파니 filed Critical 카.하.아렌스
Publication of KR880012579A publication Critical patent/KR880012579A/ko
Application granted granted Critical
Publication of KR940010179B1 publication Critical patent/KR940010179B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

니트로 에텐 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
니트로 에텐 유도체의 제조방법

Claims (8)

  1. 일반식(I)의 니트로에텐 유도체류 또는 생리적으로 적용가능한 그 염을 공정중에서,
    (I)
    [상기식중,R은또는기를 나타낸다.]
    a)일반식중(Ⅱ)의 아민
    R-CH2SCH2CH3NH2(II)
    [상기식중, R은 전술된 바와 같다.]을 일반식(III)의 화합물
    (Ⅲ)
    [상기식중, X는 할로겐원자, 또는 임의로 치환된 펜옥신기를 나타낸다.]또는 일반식(IV)의 화합물.
    (Ⅳ)
    [상기식중,X는 전술된 바와 같다.]과 반응시켜, 일반식(V)의 중간체
    (Ⅴ)
    [상기식중, R과 X는 전술된 바와 같다.]을 생성시키고, b)결과로 얻은 일반식(V)의 중간체를 메틸아민과 반응시켜 일반식(I)의 화합물을 제조하고, c)임의로, 결과를 얻어진 일반식(I)화합물을 공지방법에 의해 생리적으로 적용가능한 그 염으로 전환시켜줌을 특징으로 하는 제조방법.
  2. 제1항에 있어서, 일반식(III)에 해당하는 화합물이 1,1,1-트리클로로-2-니트로에탄임을 특징으로 하는 방법.
  3. 제1항에 있어서, 일반식(III)에 해당하는 화합물이 1,1,1-트리펜옥시-2-니트로에탄임을 특징으로 하는 방법.
  4. 제1항에 있어서, 일반식(IV)에 해당하는 화합물이 1,1,1-디클로로-2-니트로에탄임을 특징으로 하는 방법.
  5. 제1항에 있어서, 일반식(IV)에 해당하는 화합물이 1,1,1-디펜옥시-2-니트로에탄임을 특징으로 하는 방법.
  6. 제1항에 있어서, a)단계와 b)단계공정이 1단계 공정으로 수행됨을 특징으로 하는 방법.
  7. 1-[2-[[[5-[(디메틸아미노)메틸]2-푸라닐]메틸]티오]에틸아미노]-2-니트로-1-펜옥시에텐(Va)
    (Va)
  8. 1-[2-[[[2-[(디메틸아미노)메틸]-4-티아졸릴]메틸]티오]에틸아미노]-2-니트로-1-펜옥시에텐(Vb)
    (Vb)
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880003645A 1987-04-06 1988-03-31 니트로 에텐 유도체의 제조방법 KR940010179B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP87105064A EP0285681B1 (de) 1987-04-06 1987-04-06 Verfahren zur Herstellung von Nitroethenderivaten
EP?????87105064.7 1987-04-06
EP8710564.7 1987-04-06

Publications (2)

Publication Number Publication Date
KR880012579A true KR880012579A (ko) 1988-11-28
KR940010179B1 KR940010179B1 (ko) 1994-10-22

Family

ID=8196897

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880003645A KR940010179B1 (ko) 1987-04-06 1988-03-31 니트로 에텐 유도체의 제조방법

Country Status (17)

Country Link
US (1) US4968808A (ko)
EP (1) EP0285681B1 (ko)
JP (1) JP2755385B2 (ko)
KR (1) KR940010179B1 (ko)
AR (1) AR245116A1 (ko)
AT (1) ATE86619T1 (ko)
AU (1) AU597159B2 (ko)
CA (1) CA1321594C (ko)
DE (1) DE3784698D1 (ko)
DK (1) DK155488A (ko)
ES (1) ES2053462T3 (ko)
GR (1) GR3007314T3 (ko)
HU (1) HU200760B (ko)
IE (1) IE61744B1 (ko)
IL (1) IL85706A (ko)
NZ (1) NZ223844A (ko)
PT (1) PT87116B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IN181698B (ko) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
EP0697411B1 (en) * 1994-06-24 1998-07-01 Ranbaxy Laboratories Limited Process for the manufacture of pharmaceutical grade ranitidine base
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
US6069256A (en) * 1996-09-11 2000-05-30 Knoll Aktiengesellschaft Process for the preparation of nizatidine
IT1299198B1 (it) * 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
JP2002529503A (ja) 1998-11-17 2002-09-10 ニトロメッド，インク． ニトロソ化及びニトロシル化ｈ２リセプターアンタゴニスト化合物及び組成物並びにその利用方法
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US9457011B2 (en) * 2014-02-25 2016-10-04 Muslim D. Shahid Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4375547A (en) 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
ES507180A0 (es) * 1981-11-16 1982-08-16 Pharmedical Sa Lab Procedimiento de preparacion de amino alcosi furanos o tio- fenos.
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
US4625025A (en) * 1983-08-25 1986-11-25 Ube Industries, Ltd. Process for producing a 2H-1,3-thiazolidine, 2H-tetrahydro-1,3-thiazine, or 2H-hexahydro-1,3-thiazepine derivative substituted at the 2 position by a nitromethylene group derivative
EP0224612A1 (de) * 1985-12-05 1987-06-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von N-Cyano-N'-methyl-N"[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidin
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate

Also Published As

Publication number Publication date
CA1321594C (en) 1993-08-24
JP2755385B2 (ja) 1998-05-20
AR245116A1 (es) 1993-12-30
EP0285681A1 (de) 1988-10-12
PT87116A (pt) 1988-04-01
IL85706A (en) 1992-06-21
JPS63258861A (ja) 1988-10-26
EP0285681B1 (de) 1993-03-10
PT87116B (pt) 1992-07-31
IL85706A0 (en) 1988-08-31
KR940010179B1 (ko) 1994-10-22
ES2053462T3 (es) 1994-08-01
GR3007314T3 (ko) 1993-07-30
NZ223844A (en) 1989-12-21
AU597159B2 (en) 1990-05-24
US4968808A (en) 1990-11-06
DK155488A (da) 1988-10-07
IE880977L (en) 1988-10-06
ATE86619T1 (de) 1993-03-15
DE3784698D1 (de) 1993-04-15
AU1313488A (en) 1988-10-06
IE61744B1 (en) 1994-11-30
DK155488D0 (da) 1988-03-22
HU200760B (en) 1990-08-28

Similar Documents

Publication Publication Date Title
DE69327567D1 (de) Verfahren zur Herstellung von Alanylglutamin
KR870010078A (ko) 신규의 아미노산 유도체 및 그의 제조방법
KR910021366A (ko) 4-(4-알콕시페닐)-2-부틸아민 유도체 및 그의 제조방법
KR880012579A (ko) 니트로 에텐 유도체의 제조방법
KR830006198A (ko) 시클로헥산 유도체의 제조방법
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR910020004A (ko) 이소크로만 유도체
KR890012991A (ko) 광학활성을 갖는 4-옥소-1-벤조피란-2-카르복시산 유도체 및 중간체의 제법
KR900016170A (ko) 1,5-벤조티아제핀 유도체의 제조방법
KR830006243A (ko) 헤테로고리화합물 유도체의 제조방법
ES541544A0 (es) Un metodo de preparar bestatinas
KR830006231A (ko) 벤즈아졸 유도체의 제조방법
KR920012100A (ko) 비스포스폰산 유도체, 이의 제조 및 용도
KR910011839A (ko) 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제
KR850000415A (ko) 퀴나졸리논 유도체의 제조방법
KR850005441A (ko) 3-알콕시-2-(n-피롤리디노)-n-피리딜-n-푸릴메틸(또는 푸릴티에닐)-프로필아민의 제조방법
KR870010070A (ko) 모라노린 유도체의 제조법
KR840003642A (ko) 에르고트 5's-(2r-부틸)펩티드 알카로이드의 제조방법
KR840009094A (ko) 신규 아릴옥시사이클로알칸올 아미노 알킬렌아릴케톤의 제조방법
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
KR860008172A (ko) 1,3,4-티아디아졸 유도체의 제조방법
KR900701747A (ko) 아미노아세토니트릴 유도체
KR830009047A (ko) 4-(5)-알킬메르캅토이미다졸 유도체의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR900014340A (ko) 아미노에틸티아졸 및 아미노에틸옥사졸 유도체

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970827

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee